Literature DB >> 19769195

Symptoms of anal incontinence and impact on sexual function.

Minita Patel1, David M O'Sullivan, Adam C Steinberg.   

Abstract

OBJECTIVE: To evaluate whether symptoms of anal incontinence (AI) have an impact on sexual function in a cohort of women with pelvic floor disorders and/or incontinence. STUDY
DESIGN: We analyzed a cohort of women presenting to an academic urogynecology practice. The control group consisted of those who answered "no" to questions 9-11 on the Pelvic Floor Distress Inventory. The AI group consisted of those selecting "yes" to at least 1 of these questions. Student t test was used to compare differences between groups for the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12).
RESULTS: The control group had a significantly lower mean score on the PISQ-12 than the AI group. There was no difference in PISQ-12 scores when controlling for stage of prolapse.
CONCLUSION: Symptoms of AI were not associated with worse sexualfunction as measured by the PISQ-12.

Entities:  

Mesh:

Year:  2009        PMID: 19769195

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  4 in total

1.  Sexual function in women with anal incontinence using a new instrument: the PISQ-IR.

Authors:  Rachel N Pauls; Rebecca G Rogers; Mitesh Parekh; Joan Pitkin; Dorothy Kammerer-Doak; Peter Sand
Journal:  Int Urogynecol J       Date:  2014-11-13       Impact factor: 2.894

Review 2.  Sacral neuromodulation and female sexuality.

Authors:  Giuseppe Lombardi; Enrico Finazzi Agrò; Giulio Del Popolo
Journal:  Int Urogynecol J       Date:  2015-04-16       Impact factor: 2.894

Review 3.  Impact of fecal incontinence and its treatment on quality of life in women.

Authors:  Isuzu Meyer; Holly E Richter
Journal:  Womens Health (Lond)       Date:  2015-03

4.  The association between fecal incontinence and sexual activity and function in women attending a tertiary referral center.

Authors:  Sara B Cichowski; Yuko M Komesu; Gena C Dunivan; Rebecca G Rogers
Journal:  Int Urogynecol J       Date:  2013-02-07       Impact factor: 2.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.